Although composite data from separate subjects can be used to generate single-subject estimates, intersubject variation precludes rigorous ocular pharmacokinetic analysis. Therefore, a rabbit model in which sequential aqueous and vitreous humor samples were obtained following the administration of the quinolone fleroxacin was developed. Mean data from individual animals were used for pharmacokinetic analysis. Following direct intravitreal or systemic drug administration, sequential paracenteses did not alter pharmacokinetic constants or ocular penetration and were not associated with an increase in ocular protein; contamination of vitreous humor with blood was minimal (<0.1%). Following direct injection or intravenous administration, vitreous humor concentration-time data were best described by one-and two-compartment models, respectively. The maximum concentration and the penetration into the aqueous and vitreous humors were 1.54 and 0.5 ,ug/ml and 27 and 10%, respectively. Elimination rates from aqueous and vitreous humors and serum were similar following parenteral drug administration. Drug elimination following direct injection was rapid, and the elimination rate from the vitreous humor was not prolonged by the coadministration of probenecid. Our animal model provides a new approach to the rigorous examination of the ocular pharmacokinetics of quinolone antimicrobial agents in the eye.
Bacterial endophthalmitis is a severe and often blinding infection which occurs when the inner eye is seeded with microorganisms. The intraocular delivery and maintenance of therapeutic levels of antimicrobial agents into the eye, particularly the vitreous humor, continue to be vexing problems. Although intraocular drug administration in conjunction with vitrectomy preserves sight in many patients (3, 10, 11, 25, 29) , this therapy is not successful in all patients. Intraocular drug administration can cause retinal damage (9, 27) . Therefore, alternate or adjunct therapeutic modalities have been sought.
A major impediment to the development and assessment of improved drugs, delivery systems, and new approaches to therapy has been the imprecision with which intraocular pharmacokinetics are studied. Previous studies examining ocular pharmacokinetics have pooled data from different subjects to generate single-subject estimates. Unfortunately, when this approach is used to study pharmacokinetics in humans, it consistently yields inaccurate and imprecise estimates because of inter-and intrasubject variations (33) .
Since pharmacokinetic data have fundamental implications for clinical trials, we developed a rabbit model in which sequential vitreous humor samples were obtained from individual subjects. Kinetic constants from each animal were then combined to generate population data (2, 21, 23, 26) . Ocular and serum pharmacokinetics were compared. In these studies we examined the ocular pharmacokinetics of the quinolone fieroxacin. While there is limited information, fluoroquinolone penetration into the aqueous and vitreous humors ranges from 10 to 80% of that in the serum (4, 14, 15, * Corresponding author. 17, 31) . This suggests that systemic fluoroquinolone administration might provide an effective and safer adjunctive or alternative therapy to the routine use of repetitive intraocular antibiotic injections.
(This study was presented in part at the Third International Symposium on New Quinolones, Vancouver, Canada, July 1990.)
MATERIALS AND METHODS
Animal model. Adult male New Zealand White rabbits (Hare Maryland Farms, Hewitt, N.J.) weighing 2.3 to 3.0 kg were used. Prior to experimental use, antibiotic-free feed (Lab Rabbit Chow HF5326; Purina Mills Inc.) and water were provided ad libitum. The rabbits were divided into four groups: the first two groups were used to examine the effects of multiple paracenteses on pharmacokinetic parameters, erythrocyte number, and protein content; subsequent groups were used to examine the kinetics of fleroxacin in the serum and aqueous and vitreous humors after intravenous or direct injection.
The animals were anesthetized with an intramuscular dose of ketamine hydrochloride (35 (7) .
Alkaline pH and the use of mutants with alterations in the outer bacterial membrane increased the sensitivity of the biological assay (18) . Five-microliter aliquots of serum or aqueous or vitreous humor were then pipetted onto the surface of the agar and incubated overnight at 37°C in an ambient air incubator. Zones of inhibition were read by using a magnifying eyepiece calibrated to 0.1 mm. Ten standards were prepared in rabbit serum ranging from 50 to 0.05 ,ug/ml.
Regression curves for standards prepared in aqueous and vitreous humors were compared with those for standards prepared in serum, and the concentrations found in ocular compartments were adjusted accordingly. The coefficient of variation from day to day was 9.8%.
Pharmacokinetic analysis. Pharmacokinetic analyses of plasma and aqueous and vitreous humor concentration-time data following systemic administration and direct ocular administration were performed by using an iterative, nonlinear, least-squares regression program, RSTRIP (Micromath Scientific Software, Salt Lake City, Utah). The most appropriate pharmacokinetic models were determined by using the coefficient of determination and the RSTRIP model selection criterion, which is a modified form of the Akaike (1) information criterion. Estimations for each exponential coefficient and time constants were computed with the standard deviations of each estimate, along with its 95% confidence range, which was calculated by using both univariate and support plane approximations for the bounds of the 95% confidence range. On the basis of the coefficient of determination and model selection criterion, aqueous and vitreous humor and serum antibiotic concentration-time data following intravenous administration were best fitted to a twocompartment model. Concentration-time data following direct injection into the vitreous body were best fitted to the monoexponential equation describing a one-compartment model. Other standard pharmacokinetic parameters were determined by using computer-generated primary coefficients and standard pharmacokinetic equations (15) . Observed concentrations in serum and aqueous humor were used to determine maximum concentrations, times to reach maximum concentrations, and area under the concentrationtime curves (AUCs).
Statistical analysis. Overall differences in pharmacokinetic parameters among rabbits were evaluated by analysis of variance. All statistical tests were performed by using the PC version of MINITAB (W. W. Norton, New York, N.Y.). The mean and standard deviation of each pharmacokinetic variable among all rabbits in a group were also calculated. In all tests the level of significance was fixed at 0.05. An analysis of variance test was conducted. The P values, when computed, were compared against the specified level of significance of 0.05. Decision on significance or nonsignificance was therefore dependent on the value of P in relation to the specified level of significance of 0.05. In the event that a test was found to be statistically significant, Tukey's test was used to detect the means that were significantly different.
RESULTS
Characterization of the animal model. Mean antibiotic concentrations within ocular compartments such as the anterior chamber and vitreous humor cavity are proportional to the AUC. In order to show that multiple paracenteses did not alter ocular pharmacokinetics, we examined the effects of serial sampling on both kinetic constants and percent VOL. 36, 1992 on penetration. Initial studies examined the effect of paracenteses on drug elimination following direct and systemic drug administration; percent penetration was determined following systemic administration. We also measured the effect of serial paracenteses on cell count and protein concentration.
Vitreous humor kinetics following direct drug administration into the center of the vitreous humor body in five animals were studied to determine whether an increase in the number of paracenteses altered the rate of drug elimination. Since the rationale behind these experiments was that if serial paracenteses caused an alteration in the kinetics of elimination, then the slope which describes the first-order elimination rate would vary as a function of aspiration number. As shown in Fig. 1 , the concentration-time data over 8 h plotted semilogarithmically was linear with a correlation coefficient of 0.9991. On the bases of the model selection criteria and the coefficients of determination, elimination from the vitreous humor following direct injection was best fitted to a one-compartment model. There was no alteration in slope as the number of paracenteses increased, indicating that multiple vitreous humor aspirations did not alter the rate of drug elimination. This observation was significant at the 0.01 level. The initial equilibration time (diffusion from the center of the vitreous humor to the retinal surfaces) was 1.5 h (data not shown). Studies by others (12, 24) using data pooled from different subjects to measure antibiotic elimination from the vitreous body following direct injection also are best described by a one-compartment model.
To show that multiple paracenteses did not affect the percent penetration into the vitreous humor, we next examined drug concentrations following systemic administration. The mean concentration-time data for 10 animals given fleroxacin intravenously are shown in Fig. 2 sequentially sampled eyes. These data are significant at the 0.05 level.
To ensure that serial sampling was not associated with gross contamination with blood, we also measured erythrocyte counts in six eyes in animals with serial paracenteses. A grossly bloody tap was associated with >2,500 erythrocytes per mm3, corresponding to a blood/vitreous contamination factor of <0.1%. Only 5% of vitreous humor aspirates had >2,500 erythrocytes per mm3. The mean was 840 ± 414 erythrocytes per mm3.
Pharmacokinetics following intravenous administration. We next compared the pharmacokinetics of fleroxacin in serum and aqueous and vitreous humors using sequential data derived from 10 animals. Figures 3A and B show the mean levels in serum and aqueous and vitreous humors of animals given intravenous fleroxacin. These data are plotted arithmetically (Fig. 3A) to better visualize the relative penetrations of both drugs. Figure 3B shows, on a semilogarithmic plot, the data from Fig. 3A Figure 4 shows elimination from the vitreous humor following both routes of elimination. The elimination rate constant and terminal half-life following direct injection were 0.250 ± 0.005 and 2.673 h-1, respectively.
The rapid drug elimination following direct administration is particularly important, since, for other antimicrobial compounds, intravitreal administration is considered the primary route of drug administration (3, 21) . Therefore, to determine whether we could prolong the therapeutic effect of fleroxacin in the vitreous humor, we examined the effects of probenecid on quinolone elimination from the vitreous body. Probenecid is a benzoic acid derivative that inhibits the transport of organic acids across various epithelial barriers (e.g., renal tubular secretion, transport from the subarachnoid space into plasma, and biliary secretion). Systemic probenecid administration prolongs the half-life of P-lactam antibiotics in the vitreous humor because of a putative action on the retinal transport pump (6) . Since the renal tubular secretion of fleroxacin in rabbits is markedly inhibited by probenecid (34) , we examined the effect of systemically administered probenecid on fleroxacin elimination. Fleroxacin was injected directly into the vitreous humor. As shown in Fig. 5 , probenecid at 20 mg/kg, a dose that prolongs the renal elimination of fleroxacin (34) and the vitreal elimination of P-lactams (5) , had no effect on the rate of fleroxacin elimination from the vitreous humor.
DISCUSSION
An understanding of ocular pharmacokinetics is important in optimizing the therapy of bacterial endophthalmitis. Effective treatment of endophthalmitis requires that therapeutic antimicrobial levels be achieved and maintained within the vitreous humor cavity. Most studies simply describe drug penetration in the eye to determine whether therapeutic concentrations are achieved. While composite data from different subjects are occasionally pooled (11, 21, 23, 36) , this approach to pharmacokinetic analysis is limited because of intersubject variation (33) . Penetration of many antibiotics is marginal following systemic drug administra1Op- 10 Ie tion. We modified our anterior chamber model (24) to permit the analysis of complete concentration-time data in the vitreous humor. We studied a quinolone antimicrobial agent since quinolones penetrate into ocular tissue better than many other drugs (4, 14) and have excellent activity against ocular pathogens (19, 20) . The quinolone fleroxacin is slightly less active than ciprofloxacin but has a longer half-life in humans (12) . Preliminary studies suggest that quinolones, in combination with other antimicrobial agents, can be successfully incorporated into the therapy of bacterial endophthalmitis (22, 31) .
Drug concentrations were measured by a microbiological assay modified to accommodate 5-,lI samples rather than by high-pressure liquid chromatography (HPLC). The biological assay and HPLC are equivalent in sensitivity (0.01 ,jg/ml), but the latter requires 500 ,ul of fluid. As a result, the biological assay was used in these studies since, considering sample size constraints, it is two orders of magnitude more sensitive than HPLC. Both assays are equivalent despite the fact that one fleroxacin metabolite is biologically active (16) .
Traumatic paracenteses which aspirate the entire anterior chamber volume may compromise the integrity of the bloodocular barrier and thereby increase the penetration of drugs (30) . Therefore, in order to develop an in vivo ocular pharmacokinetic model that permitted repeated vitreous humor paracenteses from the same animal but that did not In subsequent studies we examined the pharmacokinetics of fleroxacin following intravenous and direct injection into the vitreous body. These studies were performed to further confirm the validity of our animal model and to show the utility of standard kinetic models by using population data in describing ocular pharmacokinetics in the vitreous and aqueous humors. The kinetics of fleroxacin following intravenous administration in the serum and aqueous and vitreous humors was described by a two-compartment open model in which absorption, distribution, and elimination followed first-order kinetics. Despite the expected differences in the concentrations of drug in the serum of individual animals, the interanimal kinetic coefficients were remarkably similar. As seen with other antimicrobial (24) and antifungal (36) compounds, drug elimination rates from the aqueous humor were similar to those from the serum. Pharmacokinetic data following direct injection into the vitreous body was described by a one-compartment model in which the rate of drug elimination followed first-order kinetics. Using composite pooled data, other investigators have also suggested that drug elimination from the vitreous body after direct administration follows first-order kinetics (8, 35) . The halflife of elimination for fleroxacin following direct injection was more rapid than that following systemic administration. However, the rate of elimination from the vitreous humor following both routes was extraordinarily rapid relative to that for other antimicrobial agents (28) and was not shortened by the coadministration of probenecid. In rabbits, the elimination of fleroxacin is more rapid than that in humans because of the increased metabolism and active tubular secretion which is blocked by probenecid (20, 34) . Rapid entry and elimination of fleroxacin in the vitreous humor indicates that elimination occurs through the retina (23) .
While these experiments were performed in uninfected animals, they provide the basis for studies examining the association between ocular pharmacokinetics and efficacy in infected animals. Importantly, even in noninflamed eyes, fleroxacin concentrations in the aqueous and vitreous humors following a single intravenous dose were in excess of the MICs for many ocular pathogens. Inflammation and the achievement of a steady state in serum both appear to increase drug penetration into the vitreous humor (23) . New investigational quinolones have excellent activity against the gram-positive pathogens (19, 26, 32, 35) that are most commonly isolated in bacterial endophthalmitis (11, 25, 29) . These observations, in conjunction with results of our pharmacokinetic studies, suggest that the fluoroquinolone antimicrobial agents may have a role in the prophylaxis and therapy of bacterial endophthalmitis. Results of our studies also provide a basis for examining the relationship between the structure-activity relationships and/or the physicochemical properties of drugs and ocular pharmacokinetics.
